🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The MIRROR study is a prospective, single center phase I feasibility and do...
Status
Unknown
Location
UMCG
Start Date
2023-05-05
Trial ID
NCT05929456
Treatments Being Tested
The esophageal squamous cell carcinoma (ESCC) has high prevalence and morta...
Status
Unknown
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Start Date
2019-11
Trial ID
NCT04161560
Treatments Being Tested
To investigate if the combination of fresh frozen sectioning based on cetux...
Status
Completed
Location
University Medical Center Groningen
Start Date
2023-03-01
Trial ID
NCT05499065
Treatments Being Tested
To date, lung resection and lymphadenectomy remain the best curative option...
Status
Unknown
Location
Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino
Start Date
2024-01
Trial ID
NCT06101394
Treatments Being Tested
Treatment of patients with locally advanced rectal cancer (LARC) is multidi...
Status
Completed
Location
University Medical Center Groningen
Start Date
2020-11-13
Trial ID
NCT04638036
Treatments Being Tested
This study is an open label, single institution, Phase 1 dose-escalation st...
Status
Terminated
Location
Stanford University, School of Medicine
Start Date
2015-11
Trial ID
NCT01987375
Treatments Being Tested
Surgery remains a main pillar in the treatment of head and neck squamous ce...
Status
Unknown
Location
University Medical Center Groningen
Start Date
2017-12-16
Trial ID
NCT03134846
Treatments Being Tested
The main treatment modality for Penile Squamous Cell Carcinoma (PSCC) is su...
Status
Completed
Location
University Medical Center Groningen
Start Date
2022-03-07
Trial ID
NCT05376202
Treatments Being Tested
This study is a phase 1-2 trial that evaluates the best dose of cetuximab-I...
Status
Terminated
Location
Stanford University, School of Medicine
Start Date
2016-10
Trial ID
NCT02855086
Treatments Being Tested
This phase 1-2 trial studies the side effects and best dose of cetuximab-IR...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2016-07
Trial ID
NCT02736578
Treatments Being Tested